KeraVet Bio

KeraVet Bio, founded in 2022, is a biotechnology startup revolutionizing veterinary wound care with its exclusive licensing of KeraNetics' patent-protected keratin technology. The company's mission, encapsulated in the slogan "The new standard of wound care is here," is to enhance the standard of care for dogs and cats by offering innovative wound management solutions. These products aim to provide significant cost savings by enabling the management of wounds before they necessitate more expensive, multi-step alternatives such as E-collars. The company's headquarters is located in the United States. The team behind KeraVet Bio brings a wealth of experience in medical research and commercialization of wound and regenerative medicine products. Their expertise spans diverse domains, including medicine and consumer healthcare, and encompasses the entire product development lifecycle, from creation and testing to the manufacturing of FDA-regulated products. KeraVet Bio recently secured a Pre Seed Round investment on April 4, 2023, with Winston-Salem Partners Roundtable (WSPR) Fund as the lead investor. With its innovative approach to veterinary wound care and the backing of WSPR Fund, KeraVet Bio is well-positioned to make a significant impact in the biotechnology industry.